icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
npC3kkcQhTcfuBRP